European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Keyphrases

Publications

volume 89, 2024

Muhammad Shaheer Bin Faheem, Ghazal Ishaque
Donanemab: An innovative solution for Alzheimer's disease? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 89 (2024)
Jelena M Wehrli, Yanfang Xia, Laura Meister, Sarrina Tursunova, Birgit Kleim, Dominik R Bach, Boris B Quednow
Forget me not: The effect of doxycycline on human declarative memory. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 89 (2024)
Marion Leboyer, Ryad Tamouza
Immuno-psychiatry: Dreams or reality? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 89 (2024)
Michele De Prisco, Vincenzo Oliva
Welcome to the jungle plot: An open letter to improve data visualization in meta-analyses. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 89 (2024)
Alessandro Miola, Mete Ercis, Vanessa K Pazdernik, Manuel Fuentes Salgado, Javier Ortiz-Orendain, Manuel Gardea-Reséndez, Peggy M Gruhlke, Ian Michel, J Michael Bostwick, Alastair J McKean, Jennifer L Vande Voort, Aysegul Ozerdem, Mark A Frye
Association between exposure to antidepressants and stimulants and age at onset of mania or psychosis: A retrospective population-based cohort study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 89 (2024)

volume 88, 2024

Marco Solmi, Giovanni Croatto, Arnav Gupta, Nicholas Fabiano, Stanley Wong, Michele Fornaro, Lynne Kolton Schneider, S Christy Rohani-Montez, Leanne Fairley, Nathalie Smith, István Bitter, Philip Gorwood, Heidi Taipale, Jari Tiihonen, Samuele Cortese, Elena Dragioti, Ebba Du Rietz, Rene Ernst Nielsen, Joseph Firth, Paolo Fusar-Poli, Catharina Hartman, Richard I G Holt, Anne Høye, Ai Koyanagi, Henrik Larsson, Kelli Lehto, Peter Lindgren, Mirko Manchia, Merete Nordentoft, Karolina Skonieczna-Żydecka, Brendon Stubbs, Davy Vancampfort, Michele De Prisco, Laurent Boyer, Eduard Vieta, Christoph U Correll, null null
Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Brooke Manning, Amie C Hayley, Luke A Downey
Response to ensuring safety in cannabinoid prescriptions: A call for critical assessment. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Daniel Umbricht, Martien J H Kas, Gerard R Dawson
The role of biomarkers in clinical development of drugs for neuropsychiatric disorders - A pragmatic guide. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Syeda Takreem Fatima
From erectile dysfunction to dementia: A new role for sildenafil. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Babette Jakobi, Priscilla Vlaming, Danique Mulder, Marta Ribases, Vanesa Richarte, Josep Antoni Ramos-Quiroga, Indira Tendolkar, Philip van Eijndhoven, Janna N Vrijsen, Jan Buitelaar, Barbara Franke, Martine Hoogman, Mirjam Bloemendaal, Alejandro Arias-Vasquez
The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Friederike Holze, Martin K Madsen, Claus Svarer, Nic Gillings, Dea S Stenbaek, Deborah Rudin, Urs Duthaler, Matthias E Liechti, Patrick M Fisher, Gitte M Knudsen
Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Babette Jakobi, Priscilla Vlaming, Danique Mulder, Marta Ribases, Vanesa Richarte, Josep Antoni Ramos-Quiroga, Indira Tendolkar, Philip van Eijndhoven, Janna N Vrijsen, Jan Buitelaar, Barbara Franke, Martine Hoogman, Mirjam Bloemendaal, Alejandro Arias-Vasquez
The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Konstantinos N Fountoulakis
Valproate use in psychiatry: New caution for an old friend? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Rosa Calvo Escalona
Clinical research in pediatric autism. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Dijana Ostojic, Paris Alexandros Lalousis, Gary Donohoe, Derek W Morris
The challenges of using machine learning models in psychiatric research and clinical practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Mojtaba Oraki Kohshour, Thomas G Schulze
Therapeutic effectiveness of anti-inflammatory monoclonal antibodies in psychiatric disorders: Challenges with an imbalanced immune system. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Derek Clougher, Silvia Amoretti
Defining the road to recovery: Cognitive reserve and resilience in severe mental illness. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Mary Bunka, Jehannine Austin, Louisa Edwards, Gavin Wong, Stirling Bryan
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Ko Yen, Chun-I Liu, Chen-Chung Liu
The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)
Christoph U Correll, Zsófia B Dombi, Ágota Barabássy, György Németh, Thomas Brevig, Roger S McIntyre
The Transdiagnostic Global Impression - Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 88 (2024)

volume 87, 2024

Laura Bueno, Albert Batalla, Mercè Balcells, Hugo López-Pelayo
Ensuring safety in cannabinoid prescriptions: A call for critical assessment. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Stefan Jerotic
Treatment or enhancement? The controversial role of medication in personality disorders. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Sydney H James, Anthony O Ahmed, Philip D Harvey, Jay B Saoud, Michael Davidson, Ramana Kuchibhatla, Remy Luthringer, Gregory P Strauss
Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Natalia E Fares-Otero, Soraya Seedat
Childhood maltreatment: A call for a standardised definition and applied framework. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Clemente Garcia-Rizo, Byron K Y Bitanihirwe
Deciphering the impact of metabolic anomalies in relation to severe mental illness. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Chantal Henry, Lucie Berkovitch
Mixed features in mood episodes: Mismatch between intensity and valence in emotional responses. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Xiaoya Fu, Yu Chen, Xingguang Luo, Jaime S Ide, Chiang-Shan R Li
Gray matter volumetric correlates of the polygenic risk of depression: A study of the Human Connectome Project data. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Simon R Poortman, Nikita Setiaman, Marjolein E A Barendse, Hugo G Schnack, Manon H J Hillegers, Neeltje E M van Haren
Non-linear development of brain morphometry in child and adolescent offspring of individuals with bipolar disorder or schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Michele De Prisco
Methodological issues around the comorbidity of obsessive-compulsive disorder and bipolar disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Robertas Strumila, Aiste Lengvenyte, Sebastien Guillaume, Benedicte Nobile, Emilie Olie, Philippe Courtet
GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)
Clara A Madsen, Miriam L Navarro, Betina Elfving, Lars V Kessing, Eero Castrén, Jens D Mikkelsen, Gitte M Knudsen
The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 87 (2024)

volume 86, 2024

Lindsay M Ham, Hannah Staunton, Jan Michael Schulz, Julian Tillmann, Dietmar Volz, Lorraine Murtagh, Christopher Chatham, Eoin C O'Connor, Stormy Chamberlain, Philipp Schoenenberger, Gahan Pandina, Paul Wang, Martien J H Kas, Celso Arango, Declan Murphy
Points to consider when initiating clinical investigations in autistic paediatric populations-A White Paper. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, Joanna Szarmach, Jakub Słupski, Adam Włodarczyk, Wiesław Jerzy Cubała
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Zuzanna Gaca, Michal Pruc, Damian Swieczkowski, Aleksander Kwaśny, Lukasz Szarpak, Wiesław J Cubała
Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Amjed Ben Haouala, Badii Amamou
Letter to editor about the article "Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis" (De Prisco M et al.,2023). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Michele De Prisco
Addressing concerns of sample overlap in meta-analysis: A response to the letter by Ben Haouala and Amamou, 2024. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Ester di Giacomo
Prader Willi syndrome, its psychiatric implications and their possible biological basis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Eva S A Dijkstra, Alexander T Sack, Martijn Arns
Does the presence of sleep disorders predict response to TMS in depression? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Vladimir Akhrimenko, Montserrat Garcia, Carmelo Aguirre, Urko Agirre, Teresa Morera-Herreras, Rafael Hernández-Palacios, Juan Medrano, Unax Lertxundi
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Dawood Javed, Faran Ahmed Jajja, Abdullah Javed
GLP-1 receptor agonists: A revolution in the treatment of Parkinson's disease? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Simon Braak, Brenda Wjh Penninx, Tanja Su, Yolande Pijnenburg, Daphne Nijland, Alba Vieira Campos, Alejandro de la Torre-Luque, Ilja M J Saris, Lianne M Reus, Amy Christine Beckenstrom, Asad Malik, Gerard R Dawson, Hugh Marston, Juan Alvarez-Linera, Jose-Luis L Ayuso-Mateos, Celso Arango, Nic van der Wee, Martien J Kas, Moji Aghajani
Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Ekin Sut, Özge Akgül, Emre Bora
Minor physical anomalies in schizophrenia and first-degree relatives in comparison to healthy controls: A systematic review and meta-analysis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Marina Mitjans, Sergi Papiol, Mar Fatjó-Vilas, Javier González-Peñas, Miriam Acosta-Díez, Marina Zafrilla-López, Javier Costas, Celso Arango, Elisabet Vilella, Lourdes Martorell, M Dolores Moltó, Julio Bobes, Benedicto Crespo-Facorro, Ana González-Pinto, Lourdes Fañanás, Araceli Rosa, Bárbara Arias
Shared vulnerability and sex-dependent polygenic burden in psychotic disorders. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Amjed Ben Haouala, Badii Amamou
Letter to editor about the article "Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis" (De Prisco M et al.,2023). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Vladimir Akhrimenko, Montserrat Garcia, Carmelo Aguirre, Urko Agirre, Teresa Morera-Herreras, Rafael Hernández-Palacios, Juan Medrano, Unax Lertxundi
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Giovana Mezzomo, Adriane R Rosa
Open science in biomedicine: Overcoming barriers in omics studies. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Giovana Mezzomo, Adriane R Rosa
Open science in biomedicine: Overcoming barriers in omics studies. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Filippo Caraci, Filippo Drago
Ketamine and new targets for treatment-resistant depression: A role for transforming growth factor-β1? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, Joanna Szarmach, Jakub Słupski, Adam Włodarczyk, Wiesław Jerzy Cubała
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)
Lindsay M Ham, Hannah Staunton, Jan Michael Schulz, Julian Tillmann, Dietmar Volz, Lorraine Murtagh, Christopher Chatham, Eoin C O'Connor, Stormy Chamberlain, Philipp Schoenenberger, Gahan Pandina, Paul Wang, Martien J H Kas, Celso Arango, Declan Murphy
Points to consider when initiating clinical investigations in autistic paediatric populations-A White Paper. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 86 (2024)